Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles

International Journal of Pharmaceutics

Volumn 342, Issue 1-2, 2007, Pages 240-249

  Jintapattanakit, Anchalee ^a,b   Junyaprasert, Varaporn B ^a   Mao, Shirui ^b,c   Sitterberg, Johannes ^b   Bakowsky, Udo ^b   Kissel, Thomas ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Insulin; Nanoparticles; PEGylated trimethyl chitosan; Peroral delivery; Polyelectrolyte complexes

Indexed keywords

CHITOSAN DERIVATIVE; INSULIN; NANOPARTICLE; POLYELECTROLYTE;

ARTICLE; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; PH; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLLOIDS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ELECTROLYTES; GELS; HYPOGLYCEMIC AGENTS; INSULIN; MOLECULAR WEIGHT; NANOPARTICLES; POLYMERS; POLYPHOSPHATES; TEMPERATURE; TRYPSIN;

EID: 34547902479     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.05.015     Document Type: Article

References (51)

1. Akiyoshi K., Kobayashi S., Shichibe S., Mix D., Baudys M., Kim S.W., and Sunamoto J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Controlled Release 54 (1998) 313-320
2. Berger J., Reist M., Mayer J.M., Felt O., and Gurny R. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur. J. Pharm. Biopharm. 57 (2004) 35-52
3. Bernkop-Schnürch A., and Dundalek K. Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation. Int. J. Pharm. 138 (1996) 75-83
4. Boonsongrit Y., Mitrevej A., and Mueller B.W. Chitosan drug binding by ionic interaction. Eur. J. Pharm. Biopharm. 62 (2006) 267-274
5. Brange J., and Langkjaer L. Chemical stability of insulin. 3: Influence of excipients, formulation, and pH. Acta Pharm. Nord. 4 (1992) 149-158
6. Calvo P., Remunan-Lopez C., Vila-Jato J.L., and Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63 (1997) 125-132
7. Carino G.P., Jacob J.S., and Mathiauty E. Nanosphere based on oral insulin delivery. J. Controlled Release 65 (2000) 261-269
8. Damagé C., Vonderscher J., Marbach P., and Pinget M. Poly(alkylcyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue. J. Pharm. Pharmacol. 49 (1997) 949-954
9. Dyer A.M., Hinchcliffe M., Watts P., Castile J., Jabbal-Gill I., Nankervis R., Smith A., and Illum L. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm. Res. 19 (2002) 998-1008
10. Fredheim G.E., and Christensen B.E. Polyelectrolyte complexes: interactions between lignosulfonate and chitosan. Biomacromolecules 4 (2003) 232-239
11. Frokjaer S., and Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Disc. 4 (2005) 298-306
12. Grenha A., Seijo B., and Remuñán-López C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur. J. Pharm. Sci. 25 (2005) 427-437
13. Hamman J.H., Schultz C.M., and Kotźe A.F. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev. Ind. Pharm. 29 (2003) 161-172
14. Iwanaga K., Ono S., Narioka K., Morimoto K., Masawo K., Yamasita S., Nange M., and Oku N. Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract. Int. J. Pharm. 157 (1997) 73-80
15. Janes K.A., and Alonso M.J. Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization. J. Appl. Polym. Sci. 88 (2003) 2769-2776
16. Knaul J.Z., Hudson S.M., and Creber K.A.M. Improved mechanical properties of chitosan fibers. J. Appl. Polym. Sci. 72 (1999) 1721-1732
17. Kotźe A.F., de Leeuw B.J., Leuβen H.L., de Boer A.G., Verhoef J.C., and Junginger H.E. Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelial: in vitro evaluation in Caco-2 cell monolayers. Int. J. Pharm. 159 (1997) 243-253
18. Kotźe A.F., Thanou M.M., Lueßen H.L., de Boer B.G., Verhoef J.C., and Junginger H.E. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability if intestinal epithelial cells (Caco-2). Eur. J. Pharm. Biopharm. 47 (1999) 269-274
19. Lenaerts V., Couvreur P., Grislain L., and Maincent P. Nanoparticles as a gastroadhesive drug delivery system. In: Lenaerts V., and Gurny R. (Eds). Bioadhesive Drug Delivery Systems (1990), CRC Press, Florida 93-104
20. Leuβen H.L., Rentel C.O., Kotźe A.F., Lehr C.M., de Boer A.G., Verhoef J.C., and Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. IV: Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J. Controlled Release 45 (1997) 14-23
21. Ma Z., Yeoh H.K., and Lim L.-Y. Formulation pH modulated the interaction of insulin with chitosan nanoparticles. J. Pharm. Sci. 91 (2002) 1396-1404
22. MacLaughlin F.C., Mumper R.J., Wang J., Tagliaferri J.M., Gill I., Hinchcliffe M., and Rolland A.P. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Controlled Release 56 (1998) 259-272
23. ® technology: mechanistic studies. Curr. Drug Deliv. 2 (2005) 191-197
24. Mao H., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., August J.T., and Leong K.W. Chitosan-DNA naoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Controlled Release 70 (2001) 399-421
25. Mao S., Shuai X., Unger F., Simon M., Bi D., and Kissel T. The depolymerization of chitosan: effects on physicochemical and biological properties. Int. J. Pharm. 281 (2004) 45-54
26. Mao S., Germershaus O., Fischer D., Linn T., Schnepf R., and Kissel T. Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm. Res. 22 (2005) 2058-2068
27. Mao S., Shuai X., Unger F., Wittmar M., Xie X., and Kissel T. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymer. Biomaterials 26 (2005) 6343-6356
28. Mao S., Bakowsky U., Jintapattanakit A., and Kissel T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J. Pharm. Sci. 95 (2006) 1035-1048
29. Morishita M., Norishita I., Takayama K., Machida Y., and Nagai T. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int. J. Pharm. 78 (1992) 1-7
30. 2EDTA and sodium glycocholate on the intestinal absorption of insulin. Biol. Pharm. Bull. 16 (1993) 68-72
31. Nakashima K., Miyagi M., Goto K., Matsumolto Y., and Ueoka R. Enzymatic and hyperglycemia stability of chemically modified insulins with hydrophobic acyl groups. Bioorg. Med. Chem. Lett. 14 (2004) 481-483
32. Owens D.R., Zinman B., and Bolli G. Alternative routes of insulin delivery. Diab. Med. 20 (2003) 886-898
33. Pan Y., Li Y., Zhao H., Zheng J., Xu H., Wei G., Hao J., and Cui F. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 249 (2002) 139-147
34. Pan Y., Zheng J., Zhao H., Li Y., Xu H., and Wei G. Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres. Acta. Pharmacol. Sin. 23 (2002) 1051-1056
35. Polnok A., Verhoef J.C., Borchard G., Sarisuta N., and Junginger H.E. In vitro evaluation of intestinal absorption of desmopressin using drug-delivery systems based on superporous hydrogels. Int. J. Pharm. 269 (2004) 303-310
36. Polnok A., Verhoef J.C., Sarisuta N., and Junginger H.E. Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur. J. Pharm. Biopharm. 57 (2004) 77-83
37. Ponchel G., and Irache J.-M. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34 (1998) 191-219
38. Sakuma S., Ishida Y., Sudo R., Suzuki N., Kikuchi H., Hiwatari K., Kishida A., Akashi M., and Hayashi M. Stabilization of salmon calcitonin by polystyrene nanoparticles having surface hydrophilic chains, against enzymatic degradation. Int. J. Pharm. 159 (1997) 181-189
39. Sandri G., Rossi S., Bonferoni M.C., Ferrari F., Zambito Y., Di Colo G., and Caramella C. Buccal penetration enhancement properties of N-trimethyl chitosan: Influence of quaternization degree on absorption of a high molecular weight molecule. Int. J. Pharm. 297 (2005) 146-155
40. Shi H.G., Farber L., Michaels J.N., Dickey A., Thompson K.C., Shelukar S.D., Hurter P.N., Reynolds S.D., and Kaufman M.J. Characterization of crystalline drug nanoparticles using atomic force microscopy and complementary techniques. Pharm. Res. 20 (2003) 479-484
41. Simon A., Wittmar M., Bakowsky U., and Kissel T. Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-2-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-vinyl alcohol)]-graft-poly(l-lactic acid): a novel carrier for transmucosal delivery of peptides. Bioconjug. Chem. 15 (2004) 841-849
42. Snyman D., Hamman J.H., and Kotzé A.F. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride. Drug Dev. Ind. Pharm. 29 (2003) 61-69
43. Snyman D., Kotzé A.F., Walls T.H., Govender T., and Lachmann G. Conformational characterization of quaternised chitosan polymers. Proc. Int. Symp. Controlled Release Bioact. Mater. 31 (2004) 211
44. Takeuchi H., Yamamoto H., and Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47 (2001) 39-54
45. Thanou M., Florea B.I., Langemeyer M.W., Verhoef J.C., and Junginger H.E. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharm. Res. 17 (2000) 27-31
46. Thanou M., Verhoef J.C., Marbach P., and Junginger H.E. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J. Pharm. Sci. 89 (2000) 951-957
47. Tsuchida E., and Takeoka S. Interpolymer Complexes and their Ion-conduction, Macromolecule Complexes in Chemistry and Biology (1994), Springer-Verlag, Berlin/Heidelberg
48. van de Merwe S.M., Verhoef J.C., Kotzé A.F., and Junginger H.E. N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations. Eur. J. Pharm. Biopharm. 57 (2004) 85-91
49. van de Weert M., Hennink W.E., and Jiskoot W. Protein instability in Poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 17 (2000) 1159-1167
50. Yamamoto A. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 11 (1994) 1496-1500
51. Yeh M. The stability of insulin in biodegradable microspheres based on blends of lactide polymers and poly (ethylene glycol). J. Microencapsul. 17 (2000) 743-756